ABVC Biopharma Inc Cash Flow-to-Debt Ratio
ABVC Biopharma Inc cash flow-to-debt ratio. ABVC Biopharma Inc (ABVC) has a Cash Flow-to-Debt Ratio of -0.03x as of June 2026, meaning its operating cash flow of $-244.41K could theoretically repay 0% of its total liabilities ($7.13 Million) in one year. Check ABVC Biopharma Inc (ABVC) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ABVC Biopharma Inc (2002–2025)
Cash flow-to-debt ratio of ABVC Biopharma Inc from 2002 to 2025. Historical debt coverage capacity for ABVC Biopharma Inc across 22 annual periods. Check how aggressively does ABVC Biopharma Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
ABVC Biopharma Inc Cash Flow-to-Debt Ratio by Year (2002–2025)
ABVC Biopharma Inc cash flow-to-debt ratio by year from 2002 to 2025. Year-by-year debt coverage analysis for ABVC Biopharma Inc. For the full cash flow conversion analysis, see ABVC Biopharma Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.38x | $-2.99 Million | $7.76 Million | ▼ -44.9% |
| 2024 | -0.27x | $-1.81 Million | $6.82 Million | ▲ +58.6% |
| 2023 | -0.64x | $-4.19 Million | $6.53 Million | ▲ +45.0% |
| 2022 | -1.17x | $-7.40 Million | $6.34 Million | ▲ +25.9% |
| 2021 | -1.57x | $-7.60 Million | $4.83 Million | ▼ -208.4% |
| 2020 | -0.51x | $-4.56 Million | $8.94 Million | ▼ -14.8% |
| 2019 | -0.44x | $-3.13 Million | $7.05 Million | ▼ -312.3% |
| 2018 | -0.11x | $-630.20K | $5.85 Million | ▲ +73.5% |
| 2017 | -0.41x | $-1.68 Million | $4.14 Million | ▲ +23.6% |
| 2016 | -0.53x | $-3.47 Million | $6.54 Million | ▼ -719.2% |
| 2015 | 0.09x | $3.36K | $39.15K | ▲ +150.0% |
| 2014 | 0.03x | $1.17K | $34.03K | ▲ +103.9% |
| 2011 | -0.87x | $-1.59 Million | $1.83 Million | ▼ -172.9% |
| 2010 | -0.32x | $-1.05 Million | $3.29 Million | ▲ +48.2% |
| 2009 | -0.62x | $-1.56 Million | $2.53 Million | ▲ +27.8% |
| 2008 | -0.85x | $-2.34 Million | $2.74 Million | ▲ +71.1% |
| 2007 | -2.95x | $-2.69 Million | $913.84K | ▼ -739.5% |
| 2006 | 0.46x | $24.45K | $53.07K | ▲ +106.8% |
| 2005 | -6.77x | $-18.43K | $2.72K | ▼ -169.5% |
| 2004 | -2.51x | $-7.45K | $2.96K | ▼ -21329.4% |
| 2003 | 0.01x | $355.00 | $30.00K | ▲ +103.5% |
| 2002 | -0.33x | $-10.00K | $30.00K | — |